Products for Research Use Only
RegisterLogin

C188

CAT: 0804-HY-112338Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-112338Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
C188 (CPD188) is a STAT3 inhibitor with anticancer effects. C188 inhibits STAT3 SH2/pY-peptide binding (IC50 of 20 µM against pY-peptide binding) and IL-6-mediated STAT3 phosphorylation. C188 is selective for STAT3 over STAT1. C188 inhibits nuclear-to-cytoplasmic translocation of Stat3. C188 shows highly active induces apoptosis in breast cancer cell lines with constitutive Stat3 activation (EC50s of 0.73 µM, 3.96 µM, and 7.01 µM in MDA-MB-468, MDA-MB-231, and MDA-MB-435 cultures, respectively) [1].
CAS Number
823828-18-8
Product Name Alternative
CPD188
UNSPSC
12352005
Target
Apoptosis; STAT
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/c188.html
Purity
98.29
Solubility
DMSO : 100 mg/mL (ultrasonic; warming)
Smiles
O=C(O)C1=CC=C(S(=O)(NC2=C3C=CC=CC3=C(O)C(SCC(O)=O)=C2)=O)C=C1
Molecular Formula
C19H15NO7S2
Molecular Weight
433.45
References & Citations
[1]Xu X, Kasembeli MM, Jiang X, Tweardy BJ, Tweardy DJ. Chemical probes that competitively and selectively inhibit Stat3 activation. PLoS One. 2009;4 (3) :e4783.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P5463C18G
HY-141580-01C18 Dihydroceramide
HY-130345-01PAF (C18)
HY-W783254C18 LPA
HY-100355-01C18-Ceramide
HY-W592010-01C18-PEG4-Azide
HY-130345S-01C18-PAF-d4
HY-100355SC18-Ceramide-d3
HY-1680744″-C18 EGCG
HY-157688-01C18 (Plasm) LPE

Alternative Products

CatalogName
BA6424-5C188
BA2725-5C188-9

Popular Products